almotriptan has been researched along with Acute Disease in 33 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 27 (81.82) | 29.6817 |
| 2010's | 6 (18.18) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Goadsby, PJ | 1 |
| Dodick, DW | 3 |
| Allena, M; Antonaci, F; Cuzzoni, MG; De Cillis, I | 1 |
| Armstrong, RB; Berenson, F; Biondi, DM; Mao, L; Pakalnis, A; Vasconcellos, E | 1 |
| Clissold, SP; Díaz-Insa, S; Lanteri-Minet, M; Leone, M; Vila, C | 1 |
| Leone, M; McGown, C; Vila, C | 1 |
| Bartolini, M; Brighina, F; Ferrari, MD; Fierro, B; Giamberardino, MA; Lisotto, C; Martelletti, P; Moscato, D; Omboni, S; Panascia, B; Pini, LA; Sances, G; Santoro, P; Savi, L; Zanchin, G | 1 |
| Slof, J | 1 |
| Reeder, CE; Williams, P | 1 |
| Cabarrocas, X; Dowson, AJ; Lainez, JM; Massiou, H | 1 |
| Gallagher, R | 1 |
| Gendolla, A | 1 |
| Láinez, M | 1 |
| Dowson, AJ | 1 |
| Dahlöf, CG; Mathew, N; Nappi, G; Sandrini, G | 1 |
| Dahlöf, CG; Dodick, DW; Dowson, AJ; Pascual, J | 1 |
| Cunha, L; Dahlöf, CG; Diener, HC; Dowson, AJ; Färkkilä, M; Goadsby, PJ; Manzoni, GC; Massiou, H; Mateos, V; Pascual, J; Raets, I | 1 |
| Galván, J; Heras, J; Láinez, MJ; Vila, C | 1 |
| Cunha, L; de Klippel, N; Diaz-Insa, S; Falques, M; Fortea, J; Geraud, G; Goadsby, PJ; Gobel, H; Ivanoff, N; Zanchin, G | 1 |
| Deleu, D; Hanssens, Y | 1 |
| Docekal, P; Falk, RM; Ferrer, P; Luria, X; Pascual, J; Piessens, F; Prusinski, A; Robert, M; Segarra, R; Zayas, JM | 1 |
| Dahlöf, C; Fazekas, A; Massiou, H; Tfelt-Hansen, P | 1 |
| Ferrari, MD; Goadsby, PJ; Lipton, RB; Roon, KI | 1 |
| Cabarrocas, X | 1 |
| Freitag, FG | 1 |
| Tfelt-Hansen, P | 1 |
| Palmer, JB; Salonen, R | 1 |
| Cates, C | 1 |
| Mathew, NT | 3 |
15 review(s) available for almotriptan and Acute Disease
| Article | Year |
|---|---|
The 'Act when Mild' (AwM) study: a step forward in our understanding of early treatment in acute migraine.
Topics: Acute Disease; Adolescent; Adult; Aged; Analgesics; Double-Blind Method; Drug Administration Schedule; Female; Humans; Hyperalgesia; Male; Middle Aged; Migraine Disorders; Multicenter Studies as Topic; Pain Measurement; Prospective Studies; Randomized Controlled Trials as Topic; Serotonin Receptor Agonists; Treatment Outcome; Tryptamines; Vasoconstrictor Agents | 2008 |
Applying the benefits of the AwM study in the clinic.
Topics: Acute Disease; Adolescent; Adult; Aged; Analgesics; Double-Blind Method; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Migraine Disorders; Multicenter Studies as Topic; Patient Satisfaction; Patients; Physician-Patient Relations; Primary Health Care; Randomized Controlled Trials as Topic; Self Administration; Serotonin Receptor Agonists; Tryptamines; Vasoconstrictor Agents | 2008 |
Almotriptan for the treatment of acute migraine: a review of early intervention trials.
Topics: Acute Disease; Clinical Trials as Topic; Disability Evaluation; Humans; Migraine Disorders; Pain Measurement; Serotonin Receptor Agonists; Tryptamines | 2010 |
Influence of trigger factors on the efficacy of almotriptan as early intervention for the treatment of acute migraine in a primary care setting: the START study.
Topics: Acute Disease; Europe; Humans; Migraine Disorders; Primary Health Care; Serotonin Receptor Agonists; Tryptamines | 2010 |
A review of the clinical efficacy and tolerability of almotriptan in acute migraine.
Topics: Acute Disease; Adult; Aged; Area Under Curve; Biological Availability; Female; Half-Life; Humans; Indoles; Male; Middle Aged; Migraine Disorders; Randomized Controlled Trials as Topic; Serotonin Receptor Agonists; Treatment Outcome; Tryptamines | 2003 |
What do patients want from acute migraine treatment?
Topics: Acute Disease; Analgesics; Attitude to Health; Clinical Trials as Topic; Disease Progression; Humans; Indoles; Migraine Disorders; Patient Acceptance of Health Care; Patient Satisfaction; Practice Patterns, Physicians'; Secondary Prevention; Serotonin Receptor Agonists; Treatment Outcome; Tryptamines | 2004 |
Clinical profile and practice experience of almotriptan.
Topics: Acute Disease; Analgesics; Attitude to Health; Clinical Trials as Topic; Disease Progression; Humans; Indoles; Migraine Disorders; Patient Satisfaction; Practice Patterns, Physicians'; Secondary Prevention; Serotonin Receptor Agonists; Treatment Outcome; Tryptamines | 2004 |
Clinical benefits of early triptan therapy for migraine.
Topics: Acute Disease; Analgesics; Attitude to Health; Clinical Trials as Topic; Disease Progression; Evidence-Based Medicine; Humans; Indoles; Migraine Disorders; Patient Satisfaction; Practice Patterns, Physicians'; Secondary Prevention; Serotonin Receptor Agonists; Treatment Outcome; Tryptamines | 2004 |
Oral almotriptan: practical uses in the acute treatment of migraine.
Topics: Acute Disease; Administration, Oral; Clinical Trials as Topic; Humans; Migraine Disorders; Serotonin Receptor Agonists; Tryptamines | 2004 |
Focus on trial endpoints of clinical relevance and the use of almotriptan for the acute treatment of migraine.
Topics: Acute Disease; Humans; Migraine Disorders; Product Surveillance, Postmarketing; Randomized Controlled Trials as Topic; Serotonin Receptor Agonists; Treatment Outcome; Tryptamines | 2005 |
Efficacy, speed of action and tolerability of almotriptan in the acute treatment of migraine: pooled individual patient data from four randomized, double-blind, placebo-controlled clinical trials.
Topics: Acute Disease; Dose-Response Relationship, Drug; Double-Blind Method; Headache; Humans; Migraine Disorders; Pain Measurement; Placebo Effect; Randomized Controlled Trials as Topic; Serotonin Receptor Agonists; Treatment Outcome; Tryptamines | 2006 |
Current and emerging second-generation triptans in acute migraine therapy: a comparative review.
Topics: Acute Disease; Carbazoles; Humans; Indoles; Migraine Disorders; Oxazoles; Oxazolidinones; Piperidines; Pyrrolidines; Receptor, Serotonin, 5-HT1B; Receptor, Serotonin, 5-HT1D; Receptors, Serotonin; Serotonin Receptor Agonists; Triazoles; Tryptamines | 2000 |
Oral triptans (serotonin 5-HT(1B/1D) agonists) in acute migraine treatment: a meta-analysis of 53 trials.
Topics: Acute Disease; Administration, Oral; Humans; Indoles; Migraine Disorders; Pyrrolidines; Randomized Controlled Trials as Topic; Recurrence; Serotonin Receptor Agonists; Severity of Illness Index; Treatment Outcome; Triazoles; Tryptamines | 2001 |
Acute treatment of migraine and the role of triptans.
Topics: Acute Disease; Blood Flow Velocity; Carbazoles; Clinical Trials as Topic; Drug Administration Routes; Female; Humans; Indoles; Male; Menstruation; Migraine Disorders; Oxazolidinones; Piperidines; Practice Guidelines as Topic; Pyrrolidines; Receptor, Serotonin, 5-HT1B; Receptor, Serotonin, 5-HT1D; Receptors, Serotonin; Serotonin Receptor Agonists; Sumatriptan; Treatment Outcome; Triazoles; Tryptamines; Vasoconstriction; Vasoconstrictor Agents | 2001 |
Almotriptan increases pain-free status in patients with acute migraine treated in placebo-controlled clinical trials.
Topics: Acute Disease; Administration, Oral; Adult; Aged; Clinical Trials, Phase III as Topic; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Migraine Disorders; Pain; Randomized Controlled Trials as Topic; Serotonin Receptor Agonists; Severity of Illness Index; Treatment Outcome; Tryptamines | 2002 |
13 trial(s) available for almotriptan and Acute Disease
| Article | Year |
|---|---|
Long-term, open-label safety study of oral almotriptan 12.5 mg for the acute treatment of migraine in adolescents.
Topics: Acute Disease; Administration, Oral; Adolescent; Child; Female; Humans; Male; Migraine Disorders; Serotonin Receptor Agonists; Time Factors; Tryptamines | 2010 |
Efficacy of almotriptan in early intervention for treatment of acute migraine in a primary care setting: the START study.
Topics: Acute Disease; Adult; Analgesics; Disabled Persons; Female; Humans; Male; Migraine Disorders; Patient Education as Topic; Prospective Studies; Recurrence; Serotonin Receptor Agonists; Treatment Outcome; Tryptamines | 2010 |
A double-blind, randomized, multicenter, Italian study of frovatriptan versus almotriptan for the acute treatment of migraine.
Topics: Acute Disease; Adolescent; Adult; Aged; Carbazoles; Cross-Over Studies; Double-Blind Method; Female; Humans; Italy; Male; Middle Aged; Migraine with Aura; Patient Preference; Serotonin Receptor Agonists; Treatment Outcome; Tryptamines; Young Adult | 2011 |
Almotriptan improves response rates when treatment is within 1 hour of migraine onset.
Topics: Acute Disease; Adolescent; Adult; Aged; Double-Blind Method; Female; Humans; Indoles; Male; Middle Aged; Migraine Disorders; Serotonin Receptor Agonists; Sumatriptan; Time Factors; Treatment Outcome; Tryptamines | 2004 |
Almotriptan and zolmitriptan in the acute treatment of migraine.
Topics: Acute Disease; Adolescent; Adult; Aged; Double-Blind Method; Female; Humans; Male; Middle Aged; Migraine Disorders; Oxazolidinones; Patient Satisfaction; Serotonin Receptor Agonists; Treatment Outcome; Tryptamines | 2007 |
Crossover, double-blind clinical trial comparing almotriptan and ergotamine plus caffeine for acute migraine therapy.
Topics: Acute Disease; Adult; Caffeine; Cross-Over Studies; Double-Blind Method; Drug Therapy, Combination; Ergotamine; Female; Humans; Male; Migraine Disorders; Nausea; Patient Satisfaction; Phosphodiesterase Inhibitors; Photophobia; Serotonin Receptor Agonists; Treatment Outcome; Tryptamines; Vasoconstrictor Agents | 2007 |
Early vs. non-early intervention in acute migraine-'Act when Mild (AwM)'. A double-blind, placebo-controlled trial of almotriptan.
Topics: Activities of Daily Living; Acute Disease; Adolescent; Adult; Aged; Double-Blind Method; Female; Humans; Male; Middle Aged; Migraine with Aura; Migraine without Aura; Neck Pain; Placebos; Recurrence; Serotonin Receptor Agonists; Severity of Illness Index; Shoulder Pain; Time Factors; Treatment Outcome; Tryptamines | 2008 |
Consistent efficacy and tolerability of almotriptan in the acute treatment of multiple migraine attacks: results of a large, randomized, double-blind, placebo-controlled study.
Topics: Acute Disease; Adolescent; Adult; Aged; Analgesics; Coronary Angiography; Dose-Response Relationship, Drug; Double-Blind Method; Electrocardiography; Female; Humans; Indoles; Male; Middle Aged; Migraine Disorders; Molecular Structure; Myocardial Ischemia; Reproducibility of Results; Safety; Serotonin Receptor Agonists; Time Factors; Treatment Outcome; Tryptamines | 2000 |
Dose finding, placebo-controlled study of oral almotriptan in the acute treatment of migraine.
Topics: Acute Disease; Administration, Oral; Adult; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Indoles; Male; Middle Aged; Migraine Disorders; Pain Measurement; Treatment Outcome; Tryptamines | 2001 |
Efficacy and tolerability of subcutaneous almotriptan for the treatment of acute migraine: a randomized, double-blind, parallel-group, dose-finding study.
Topics: Acute Disease; Adolescent; Adult; Aged; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Indoles; Injections, Subcutaneous; Male; Middle Aged; Migraine Disorders; Serotonin Receptor Agonists; Tryptamines | 2001 |
Almotriptan increases sustained pain-free outcomes in acute migraine: results from three controlled clinical trials.
Topics: Acute Disease; Adult; Female; Humans; Indoles; Male; Middle Aged; Migraine Disorders; Palliative Care; Randomized Controlled Trials as Topic; Serotonin Receptor Agonists; Sumatriptan; Treatment Outcome; Tryptamines | 2002 |
A long-term open-label study of oral almotriptan 12.5 mg for the treatment of acute migraine.
Topics: Acute Disease; Administration, Oral; Adult; Aged; Dose-Response Relationship, Drug; Female; Humans; Indoles; Longitudinal Studies; Male; Middle Aged; Migraine Disorders; Serotonin Receptor Agonists; Treatment Outcome; Tryptamines | 2002 |
Use of rescue medication in trials of almotriptan versus placebo in the treatment of acute migraine.
Topics: Acute Disease; Adolescent; Adult; Aged; Double-Blind Method; Female; Humans; Indoles; Male; Middle Aged; Migraine with Aura; Migraine without Aura; Multicenter Studies as Topic; Tryptamines | 2002 |
5 other study(ies) available for almotriptan and Acute Disease
| Article | Year |
|---|---|
Cost-effectiveness analysis of early versus non-early intervention in acute migraine based on evidence from the 'Act when Mild' study.
Topics: Acute Disease; Cost-Benefit Analysis; Early Medical Intervention; France; Humans; Migraine Disorders; Quality-Adjusted Life Years; Randomized Controlled Trials as Topic; Serotonin Receptor Agonists; Tryptamines | 2012 |
Cost-effectiveness of almotriptan and rizatriptan in the treatment of acute migraine.
Topics: Acute Disease; Cost-Benefit Analysis; Decision Support Techniques; Female; Health Care Costs; Health Services; Humans; Indoles; Male; Migraine Disorders; Serotonin Receptor Agonists; Triazoles; Tryptamines | 2003 |
Triptan medications to treat acute migraine.
Topics: Acute Disease; Clinical Trials as Topic; Humans; Indoles; Meta-Analysis as Topic; Migraine Disorders; Serotonin Receptor Agonists; Sumatriptan; Tryptamines | 2002 |
Triptan medications to treat acute migraine.
Topics: Acute Disease; Humans; Indoles; Meta-Analysis as Topic; Migraine Disorders; Serotonin Receptor Agonists; Sumatriptan; Tryptamines | 2002 |
Triptan medications to treat acute migraine.
Topics: Acute Disease; Humans; Indoles; Meta-Analysis as Topic; Migraine Disorders; Serotonin Receptor Agonists; Sumatriptan; Tryptamines | 2002 |